stars 1 stars 2 stars 3

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.

View Top Employees from BlueRock Therapeutics
Website http://www.bluerocktx.com
Revenue $42.3 million
Employees 484 (484 on RocketReach)
Founded 2016
Address 238 Main St, Cambridge, Massachusetts 02142, US
Phone (857) 777-0512
Technologies
Industry Biotechnology Research, Drug Manufacturing & Research, Biopharma, Stem Cell Therapeutics, Pharmaceuticals, Biotechnology, Engineered Cell Therapy, Healthcare, Health Care, Cardiology, Science and Engineering, Neurology, Immunology, Regenerative Medicine, Cell+Gene
Competitors Applied StemCell, CBMG Holdings, Gamida Cell Ltd., SanBio, ViaCyte
SIC SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies

BlueRock Therapeutics Questions

The BlueRock Therapeutics annual revenue was $42.3 million in 2024.

Craig Beasley is the CTO of BlueRock Therapeutics.

484 people are employed at BlueRock Therapeutics.

BlueRock Therapeutics is based in Cambridge, Massachusetts.

The NAICS codes for BlueRock Therapeutics are [54, 541711, 541, 54171, 5417].

The SIC codes for BlueRock Therapeutics are [283, 80, 28, 873, 87].

Top BlueRock Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users